Interpretation of the Humphrey Matrix 24-2 test in the diagnosis of preperimetric glaucoma

[1] Quigley H.A.(1982)Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy Arch Ophthalmol 100 135-146

[2] Addicks E.M.(1999)Ganglion cell losses underlying visual field defects from experimental glaucoma Invest Ophthalmol Vis Sci 40 2242-2250

[3] Green W.R.(2000)Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons Invest Ophthalmol Vis Sci 41 741-748

[4] Harwerth R.S.(2000)Frequency doubling technology perimetry for detection of glaucomatous visual field loss Am J Ophthalmol 129 314-322

[5] Carter-Dawson L.(1997)Screening for glaucomatous visual fi eld loss with frequency-doubling perimetry Invest Ophthalmol Vis Sci 38 413-425

[6] Shen F.(2000)Comparison of frequency doubling perimetry with Humphrey visual field analysis in a glaucoma practice Am J Ophthalmol 129 328-333

[7] Kerrigan-Baumrind L.A.(2005)Characteristics of the normative database for the Humphrey Matrix perimeter Invest Ophthalmol Vis Sci 46 1540-1548

[8] Quigley H.A.(1996)Frequency doubling in visual responses Opt Soc Am 56 1628-1633

[9] Pease M.E.(2002)Mechanisms isolated by frequency doubling technology perimetry Invest Ophthalmol Vis Sci 43 398-401

[10] Cello K.E.(2004)Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss Am J Ophthalmol 137 863-371

[1] Quigley H.A.(1982)Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy Arch Ophthalmol 100 135-146

[2] Addicks E.M.(1999)Ganglion cell losses underlying visual field defects from experimental glaucoma Invest Ophthalmol Vis Sci 40 2242-2250

[3] Green W.R.(2000)Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons Invest Ophthalmol Vis Sci 41 741-748

[4] Harwerth R.S.(2000)Frequency doubling technology perimetry for detection of glaucomatous visual field loss Am J Ophthalmol 129 314-322

[5] Carter-Dawson L.(1997)Screening for glaucomatous visual fi eld loss with frequency-doubling perimetry Invest Ophthalmol Vis Sci 38 413-425

[6] Shen F.(2000)Comparison of frequency doubling perimetry with Humphrey visual field analysis in a glaucoma practice Am J Ophthalmol 129 328-333

[7] Kerrigan-Baumrind L.A.(2005)Characteristics of the normative database for the Humphrey Matrix perimeter Invest Ophthalmol Vis Sci 46 1540-1548

[8] Quigley H.A.(1996)Frequency doubling in visual responses Opt Soc Am 56 1628-1633

[9] Pease M.E.(2002)Mechanisms isolated by frequency doubling technology perimetry Invest Ophthalmol Vis Sci 43 398-401

[10] Cello K.E.(2004)Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss Am J Ophthalmol 137 863-371